BIO-key International
HOLMDEL, New Jersey, United States · Biometrics, Cyber Security, Information Technology
BIO-key has over two decades of expertise in providing authentication technology for thousands of organizations and millions of users and is revolutionizing authentication with biometric-centric, multi-factor identity and access management (IAM) solutions, including its PortalGuard IAM solution, that provides convenient and secure access to devices, information, applications, and high-value transa
You have opened 5 full company profiles today. Create an account to keep reading them. Create an account
Key facts
- Headquarters
- HOLMDEL, New Jersey, United States
- Employees
- Unknown
- Industries
- Biometrics, Cyber Security, Information Technology
- Status
- Public (BKYI)
- Website
- www.bio-key.com
- Company page
Recent activity at BIO-key International
- : SEC 8-K (1.01): On September 29, 2026, BIO-key International, Inc. entered into four separate Exchange Agreements with Streeterville Capital, LLC. This involved the partitioning of a previously issued Secured Promissory Note totaling $1,130,000 into four new Promissory Notes with principal amounts of $68,315.80, $116,000, $117,000, and $115,000. The outstanding balance of the Original Note was reduced by $416,315.80, effectively paying it off. Additionally, the Company exchanged these Partitioned Notes for a total of 247,805 shares of its Common Stock, thereby impacting its equity structure and alleviating debt obligations.
- : SEC 8-K (2.02): On August 13, 2026, BIO-key International, Inc. announced its financial results for the second quarter of 2026. The press release detailed key financial metrics, including revenue and earnings, which are critical for investors evaluating the company's performance. This filing includes the press release attached as Exhibit 99, indicating the company's ongoing operations and potential growth trajectory. The announcement date of August 13, 2026, reflects the timely nature of this financial update, which is crucial for market participants.
- : SEC 8-K (1.01): On August 10, 2026, BIO-key International, Inc. entered into a Warrant Exercise Agreement with an institutional investor to exercise 618,334 existing warrants for its common stock, reducing the exercise price from $10.20 to $4.06 per share. In exchange for exercising these existing warrants, the investor received new unregistered warrants for an additional 1,236,668 shares, also priced at $4.06 per share. This transaction reflects a strategic adjustment in the financial terms to encourage warrant exercise and enhance liquidity for the company, impacting its capitalization structure significantly.
Employee benefit plans
BIO-key International files 4 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
About BIO-key International: questions and answers
What does BIO-key International do?
BIO-key has over two decades of expertise in providing authentication technology for thousands of organizations and millions of users and is revolutionizing authentication with biometric-centric, multi-factor identity and access management (IAM) solutions, including its PortalGuard IAM solution, that provides convenient and secure access to devices, information, applications, and high-value transa
Where is BIO-key International headquartered?
BIO-key International is headquartered in HOLMDEL, New Jersey, United States.
What is the latest news on BIO-key International?
On Sep 29, 2026, SEC 8-K (1.01): On September 29, 2026, BIO-key International, Inc. entered into four separate Exchange Agreements with Streeterville Capital, LLC. This involved the partitioning of a previously issued Secured Promissory Note totaling $1,130,000 into four new Promissory Notes with principal amounts o
Is BIO-key International a public company?
Yes. BIO-key International is publicly traded under the ticker BKYI.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy